Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Nektar Therapeutics buy BiotechBee

Nektar Therapeutics
Start price
€40.80
14.09.25 / 70%
Target price
€100.00
28.11.27
Performance (%)
-0.49%
End price
€40.60
15.09.25
Summary
This prediction ended on 15.09.25 with a price of €40.60. During the runtime of the prediction for Nektar Therapeutics the price only changed by -0.49%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m
Nektar Therapeutics - -
iShares Core DAX® 0,79 % 1,97 %
iShares Nasdaq 100 4,23 % 4,34 %
iShares Nikkei 225® 3,29 % 6,99 %
iShares S&P 500 2,50 % 2,76 %

According to BiotechBee what are the pros and cons of Nektar Therapeutics for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Nektar Therapeutics diskutieren
Prediction Buy
Perf. (%) -0.49%
Target price 100.000
Change
Ends at 28.11.27

Buy mit Kursziel 100,0

BiotechBee 
0
Report Share
14.09.25
In the thread Trading Nektar Therapeutics
Prediction Buy
Perf. (%) -0.49%
Target price 100.000
Change
Ends at 28.11.27

Buy beendet

BiotechBee 
0
Report Share
15.09.25